Skip to main content
. 2023 Apr 10;38(10):2298–2309. doi: 10.1093/ndt/gfad068

Table 3:

Intradialytic variables related to RCA during PIKRT.

Variable SLED start SLED 2 h SLED 4 h SLED 6 h SLED 8 h ANOVA P
ACT, s 115.6 (13.5) 118.0 (13.1) 117.1 (12.1) 116.5 (15.0) 119.2 (15.9) F(2.94, 70.65) = 0.991 .401
s-Ca2+, mmol/L 1.13 (0.09) 1.14 (0.07) 1.16 (0.08)** 1.20 (0.05)*,***,**** 1.20 (0.06) F(1.77, 42.49) = 8.823 <.001
c-Ca2+, mmol/L NA 0.40 (0.04) NA NA NA NA NA
CaCl2, mL/h 11.1 (0.5) 11.7 (1.4) 11.9 (2.2) 11.5 (2.2) 11.4 (2.1) F(1.49, 35.67) = 2.207 .137
HCO3, mmol/L 21.9 (2.2) 21.3 (1.8) 21.6 (1.8) 21.5 (1.6) 21.4 (1.8) F(1.70, 40.88) = 1.826 .178
Lactate, mmol/L 1.19 (0.64) 1.27 (0.50 NA NA NA NA .177
Citrate, mmol/L 0.58 ± 0.19 NA 0.70* ± 0.23 0.72* ± 0.27 0.74* ± 0.22 F(3, 57) = 18.42 <.001

*P < .01 in comparison with baseline; **P < .05 in comparison with 2 h; ***P < .01 in comparison with 2 h; ****P < .05 in comparison with 4 h.

Data are presented as mean (SD). Values are intended as measured on patients’ blood if not otherwise indicated. P-values refer to test for trend across all the available sample times.

ACT, activated clotting time; s-Ca2+, systemic ionized calcium; c-Ca2+, circuit ionized calcium; CaCl2, calcium chloride infusion; HCO3, bicarbonate; NA, not available.